直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Securing $240 million and a jury verdict of willful infringement for Promptu in patent case against Comcast

Promptu Systems Corporation

US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)

US Synthetic Corporation

Achieving precedent in preserving valuable patents for Lumify®

Eye Therapies, LLC

Finnegan client Maglula delivers crushing blow to Amazon’s arbitration practices over counterfeit products

Maglula, Ltd.

Finnegan secures $180M for CSRC in complex arbitrations

CSRC et al.

Protecting a blockbuster diabetes treatment for AstraZeneca

AstraZeneca AB

Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini

Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Recent Experience

Experience

In re Lumify

In re Lumify

3:21-cv-16766, D.N.J., Judges Kirsch, Singh
IPR2022-00146, PTAB, Judges Hulse, New, Pollock
IPR2024-00467, PTAB, Judges Flax, Pollock, Yang
IPR2022-00142, PTAB, Judges Flax, Hulse, New, Pollock

Experience

Bausch Health Ireland Limited et al. v. Aurobindo Pharma Limited et al.

Bausch Health Ireland Limited et al. v. Aurobindo Pharma Limited et al.

2:23-cv-00170, D.N.J., Judge Chesler
1:21-cv-00611, D. Del., Judge Stark
1:22-cv-00085, N.D.W. Va., Judge Kleeh
2:21-cv-00573, W.D. Pa., Judges Cercone, Hardy
1:22-cv-00020, N.D.W. Va., Judge Kleeh
2:21-cv-10057, D.N.J., Judge Chesler
2:21-cv-10403, D.N.J., Judge Chesler
2:23-cv-03333, D.N.J., Judge Chesler
1:24-cv-00036, N.D.W. Va., Judge Kleeh
2:24-cv-07182, D.N.J., Judge Chesler
2:24-cv-11179, D.N.J., Judge Chesler
1:25-cv-00003, N.D.W. Va., Judge Kleeh
IPR2023-00016, PTAB, Judges Hardman, Hulse, Valek
IPR2022-00722, - 01102, -01103, -01104, -01105, PTAB, Judges Hardman, Hulse, Snedden, Valek

Experience

AbbVie Inc., et al. v. Aurobindo Pharma U.S.A., Inc. et al.

AbbVie Inc., et al. v. Aurobindo Pharma U.S.A., Inc. et al.

3:24-cv-04603, D.N.J., Judges Quraishi, Day
3:24-cv-04662, D.N.J., Judges Quraishi, Day
3:24-cv-04852, D.N.J., Judges Quraishi, Day

Experience

Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al. Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.

1:21-cv-01736, 1:23-cv-00554, D. Del., Judge Andrews

Experience

Representative Engagement: Finnegan revives key Jublia® patent at the Federal Circuit - Kaken Pharmaceutical Co., Ltd. et al v. Iancu, 18-2232, Fed. Cir.

Finnegan revives key Jublia® patent at the Federal Circuit Finnegan revives key Jublia® patent at the Federal Circuit

3:18-cv-13635, D.N.J., Judges Martinotti, Goodman
18-2232, Fed. Cir., Judges Newman, O'Malley, Taranto
IPR2017-00190, PTAB, Judges Mitchell, Franklin, Pollock
IPR2017-01429, PTAB, Judges Mitchell, Franklin, Pollock

Experience

American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al. American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al.

PGR2020-00009, PTAB, Judges Tornquist, Franklin, Wisz
3:20-cv-01350, D.N.J., Judges Goodman, Martinotti, Quraishi

Experience

Sandoz, Inc. et al v. Pharmacyclics LLC Sandoz, Inc. et al v. Pharmacyclics LLC

IPR2019-00865, PTAB, Judges Cotta, Snedden, Mitchell

Experience

Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al. Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.

1:18-cv-01895, D. Del., Judges Andrews, Fallon

Experience

In re Fetzima In re Fetzima

2:17-cv-10230, D.N.J., Judges Mannion, Salas

Experience

Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al. Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.

IPR2018-01403, PTAB, Judges Chagnon, Harlow, Snedden

Experience

Ajinomoto Co., Inc. et al. v. CJ Cheiljedang Corp. et al. Ajinomoto Co., Inc. et al. v. CJ Cheiljedang Corp. et al.

1:16-cv-03498, S.D.N.Y., Judges Gorenstein, Vyskocil
337-TA-1005, ITC, Judges Bullock, Essex
18-1590, -1629, Fed. Cir., Judges Dyk, Moore, Taranto
IPR2017-01551, -01698, PTAB, Judges Franklin, Mitchell, Moore, Sawert, Yang

Experience

Highmark, Inc. v. Allcare Health Management System, Inc. Highmark, Inc. v. Allcare Health Management System, Inc.

12-1163, S. Ct., Judges Alito, Breyer, Ginsburg, Kagan, Kennedy, Roberts, Scalia, Sotomayor, Thomas
11-1219, Fed. Cir., Judges Dyk, Mayer, Newman
4:03-cv-01384, N.D. Tex., Judges Lancaster, Means

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP